Fennec Pharmaceuticals
FENC
84 hedge funds and large institutions have $130M invested in Fennec Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 5 closing their positions.
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
15% more capital invested
Capital invested by funds: $113M → $130M (+$16.9M)
8% more funds holding
Funds holding: 78 → 84 (+6)
4% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 25
0.39% more ownership
Funds ownership: 49.27% → 49.67% (+0.39%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$2.72M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.98M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$526K |
| 4 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$270K |
| 5 |
Jane Street
New York
|
+$196K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HFA
Harbert Fund Advisors
Birmingham,
Alabama
|
-$950K |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$653K |
| 3 |
LPC
Lion Point Capital
New York
|
-$629K |
| 4 |
SCM
Solas Capital Management
Darien,
Connecticut
|
-$390K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$258K |
FENC Hedge Fund Activity: Q3 2025 in Review
84 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q3 2025, worth a combined $130M — up 15% from $113M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new FENC positions and 5 closed out — a net gain of 6 holders — while 26 added to existing stakes and 25 trimmed.
The largest buyer was Tang Capital Management, adding an estimated $2.72M. The largest seller was Harbert Fund Advisors, cutting an estimated $950K.
- 84 institutional investors held Fennec Pharmaceuticals (FENC) as of Q3 2025, up from 78 in Q2 2025.
- Funds reported $130M of Fennec Pharmaceuticals stock for Q3 2025, up 15% quarter-over-quarter.
- 11 funds opened new Fennec Pharmaceuticals positions in Q3 2025 and 5 closed out, a net change of +6 holders.
- The largest Fennec Pharmaceuticals buyer in Q3 2025 was Tang Capital Management, an estimated $2.72M added.
- The largest Fennec Pharmaceuticals seller in Q3 2025 was Harbert Fund Advisors, an estimated $950K sold.
Based on aggregated 13F filings for Q3 2025.